Your browser doesn't support javascript.
loading
Targeting DNMTs to Overcome Enzalutamide Resistance in Prostate Cancer.
Farah, Elia; Zhang, Zhuangzhuang; Utturkar, Sagar M; Liu, Jinpeng; Ratliff, Timothy L; Liu, Xiaoqi.
Afiliação
  • Farah E; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
  • Zhang Z; Department of Biochemistry, Purdue University, West Lafayette, Indiana.
  • Utturkar SM; Department of Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky.
  • Liu J; Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana.
  • Ratliff TL; Markey Cancer Center, University of Kentucky, Lexington, Kentucky.
  • Liu X; Purdue University Center for Cancer Research, Purdue University, West Lafayette, Indiana.
Mol Cancer Ther ; 21(1): 193-205, 2022 01.
Article em En | MEDLINE | ID: mdl-34728570
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Benzamidas / Resistencia a Medicamentos Antineoplásicos / Neoplasias de Próstata Resistentes à Castração / DNA (Citosina-5-)-Metiltransferase 1 / Nitrilas Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Feniltioidantoína / Benzamidas / Resistencia a Medicamentos Antineoplásicos / Neoplasias de Próstata Resistentes à Castração / DNA (Citosina-5-)-Metiltransferase 1 / Nitrilas Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article